ANAB vs EIX · rev $91.3M vs P/E 7.3, rev $17.60B
AnaptysBio Inc (ANAB) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ANAB currently screens at market cap $1.62B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ANAB and EIX stock pages for the full models.
Not investment advice.